Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients.
Heliyon
; 9(1): e12704, 2023 Jan.
Article
em En
| MEDLINE
| ID: mdl-36594041
ACE2, angiotensin-converting enzyme; AUC, area-under-the-curve; Adaptive immunity; Antibodies; COPD, chronic obstructive pulmonary disease; COVID-19; COVID-19, coronavirus disease 2019; ICU, intensive care unit; IQR, interquartile range; Intensive care units; MFI, median fluorescence intensity; MODS, multi-organ dysfunction score; Neutralizing; P/F, arterial partial pressure to inspired oxygen; RBD, receptor binding domain; REB, research ethics board; ROC, receiver operating characteristic; SARS-CoV-2; SARS-CoV-2 alpha variant; SARS-CoV-2 beta variant; SARS-CoV-2 delta variant; SARS-CoV-2 gamma variant; SOFA, sequential organ failure assessment; VOC, variants of concern; VTE, venous thromboembolism; WT, wild-type
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Heliyon
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Canadá
País de publicação:
Reino Unido